COVID-19 Vaccine Trial Data from Pfizer Likely Delayed

November 3, 2020

COVID-19 Vaccine Trial Data from Pfizer Likely Delayed

Although Pfizer started clinical trials with a goal of releasing data by the beginning of November, that has become unlikely. CEO Albert Bourla announced that the company doesn’t anticipate sharing information on its trial until about a week after the data and safety monitoring board conducts its review of the company’s phase three vaccine trial. Yourway has two decades of experience and a robust global footprint, which allows us to deliver faster turnaround times.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

SCOPE Supply Chain & Logistics Leadership Summit

February 2-5, 2026
Orlando, Florida

Schedule a Meeting

Global Clinical Supplies Group Asia Pacific Conference

March 11-13, 2026
Conrad Seoul Hotel, South Korea

Schedule a Meeting

Media

Articles

Just-in-Time or Plan Ahead? Mastering Logistics Strategies for Complex Clinical Trials

Open chat

Hello! How can I help you?